Rinda Sama - 10 Aug 2022 Form 4 Insider Report for Axonics, Inc.

Role: Chief Operating Officer
Signature: /s/ Dan Dearen, as Attorney-in-Fact for Rinda Sama
Issuer symbol: N/A
Transactions as of: 10 Aug 2022
Net transactions value: -$1,777,778
Form type: 4
Filing time: 12 Aug 2022, 19:48:32 UTC
Previous filing: 09 Aug 2022
Next filing: 02 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXNX	Common Stock	Options Exercise	$229,552	+16,177	+30%	$14.19^*	70,835	10 Aug 2022	Direct
transaction	AXNX	Common Stock	Options Exercise	$214,332	+8,301	+12%	$25.82	79,136	10 Aug 2022	Direct
transaction	AXNX	Common Stock	Options Exercise	$132,989	+9,372	+12%	$14.19^*	88,508	10 Aug 2022	Direct
transaction	AXNX	Common Stock	Sale	$1,697,486	-24,478	-28%	$69.35	64,030	10 Aug 2022	Direct	F1, F2
transaction	AXNX	Common Stock	Sale	$657,165	-9,372	-15%	$70.12	54,658	10 Aug 2022	Direct	F1, F3
holding	AXNX	Common Stock						4,000	10 Aug 2022	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXNX	Stock Options (Right to buy)	Options Exercise	$0	-25,549	-70%	$0.000000	11,019	10 Aug 2022	Common Stock	25,549	$14.19	Direct	F4
transaction	AXNX	Stock Options (Right to buy)	Options Exercise	$0	-8,301	-45%	$0.000000	9,962	10 Aug 2022	Common Stock	8,301	$25.82	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2	This transaction was executed in multiple trades at prices ranging from $68.98 to $69.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3	This transaction was executed in multiple trades at prices ranging from $70.00 to $70.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4	The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on January 30th, 2020, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of January 30th, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
F5	The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on December 12, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on December 12, 2023, provided the reporting person remains in continuous service on each vesting date.